Obesity Surgery During 2020 Italian Pandemic

UnknownOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

May 30, 2021

Conditions
Bariatric Surgery CandidateCovid19Complication of Surgical ProcedurePneumonia, ViralViral InfectionObesity, MorbidSafety IssuesReadmission
Interventions
PROCEDURE

Bariatric procedures

All standard, laparoscopic bariatric procedures endorsed by SICOB (Società Italiana della Chirurgia dell'Obesità, Italian Society of Obesity Surgery) and by IFSO (International Federation of the Societies of Obesity Surgery), will be considered: sleeve gastrectomy, R-en-Y gastric bypass, one anastomosis gastric bypass, single anastomosis duodeno-ileal bypass with sleeve. The selection criteria for the surgery candidates will comply to the latest guidelines for bariatric surgery endorsed by SICOB, IFSO and EAES (European Association of Endoscopic Surgery). All the participating centers will follow the usual recruitment protocol. Restart of the bariatric elective surgery is based on the guidelines of SICOB for the bariatric surgery restart in Italy during the COVID-19 phase 2-3 of endemics.

Trial Locations (1)

04100

RECRUITING

University La Sapienza of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Latina

All Listed Sponsors
collaborator

Azienda Ospedaliero, Universitaria Pisana

OTHER

collaborator

Azienda Ospedaliera di Padova

OTHER

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

collaborator

IRCCS Policlinico S. Donato

OTHER

collaborator

University of Rome Tor Vergata

OTHER

collaborator

A.O.U. Città della Salute e della Scienza

OTHER

collaborator

Humanitas Clinical and Research Center

OTHER

collaborator

Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy

OTHER

lead

University of Roma La Sapienza

OTHER